EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Structure-based design of novel heterocycle-substituted ATDP analogs as non-nucleoside reverse transcriptase inhibitors with improved selectivity and solubility

Li-Min Zhao, Christophe Pannecouque, Erik De Clercq, Shuai Wang, Fen-Er Chen

Acta Pharmaceutica Sinica B · 2023-12 · 13 (12) · 4906-4917

DOI: 10.1016/j.apsb.2023.07.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2023-12. Verfasst von Li-Min Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Natural Resources of Changbai Mountain & Functional Molecules, Ministry of Education, Yanbian University College of Pharmacy, Yanbi…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fudan University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ATDPHIV-1NNRTIsPyridoneRT

Autor:innen und Institutionen

  • Key Laboratory of Natural Resources of Changbai Mountain & Functional Molecules, Ministry of Education, Yanbian University College of Pharmacy, Yanbian University, Yanji 133002, China.
  • Engineering Center of Catalysis and Synthesis for Chiral Molecules, Department of Chemistry, Fudan University, Shanghai 200433, China.
  • Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs, Shanghai 200433, China.
  • Rega Institute for Medical Research, KU Leuven, Leuven B-3000, Belgium.

Förderung

  • Fudan University
  • National Natural Science Foundation of China

Zitieren

APA

Zhao, L. M., Pannecouque, C., Clercq, E., Wang, S., & Chen, F. E. (2023). Structure-based design of novel heterocycle-substituted ATDP analogs as non-nucleoside reverse transcriptase inhibitors with improved selectivity and solubility. Acta Pharmaceutica Sinica B, 13(12), 4906-4917. https://doi.org/10.1016/j.apsb.2023.07.008

Vancouver

Zhao LM, Pannecouque C, Clercq E, Wang S, Chen FE. Structure-based design of novel heterocycle-substituted ATDP analogs as non-nucleoside reverse transcriptase inhibitors with improved selectivity and solubility. Acta Pharmaceutica Sinica B. 2023;13(12):4906-4917. doi:10.1016/j.apsb.2023.07.008

BibTeX
@article{Zhao2023,
  author = {Zhao, Li-Min and Pannecouque, Christophe and Clercq, Erik De and Wang, Shuai and Chen, Fen-Er},
  title = {Structure-based design of novel heterocycle-substituted ATDP analogs as non-nucleoside reverse transcriptase inhibitors with improved selectivity and solubility},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2023},
  volume = {13},
  number = {12},
  pages = {4906--4917},
  doi = {10.1016/j.apsb.2023.07.008}
}
Kostenlos starten →